×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VCYT – veracyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VCYT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
10:31 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
11/15
08:28 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
11/9
08:53 am
vcyt
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Medium
Report
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/8
10:34 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
11/8
06:36 am
vcyt
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/7
12:35 pm
vcyt
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
Medium
Report
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
11/7
12:32 pm
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
11/7
11:20 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
04:23 pm
vcyt
Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN
Low
Report
Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN
11/14
04:36 pm
vcyt
Form 4 VERACYTE, INC. For: Nov 12 Filed by: EPSTEIN ROBERT S
Low
Report
Form 4 VERACYTE, INC. For: Nov 12 Filed by: EPSTEIN ROBERT S
11/14
04:36 pm
vcyt
Form 4 VERACYTE, INC. For: Nov 12 Filed by: Chambers Rebecca
Low
Report
Form 4 VERACYTE, INC. For: Nov 12 Filed by: Chambers Rebecca
11/12
04:30 pm
vcyt
Form 144 VERACYTE, INC. Filed by: EPSTEIN ROBERT S
Medium
Report
Form 144 VERACYTE, INC. Filed by: EPSTEIN ROBERT S
11/12
04:29 pm
vcyt
Form 144 VERACYTE, INC. Filed by: Chambers Rebecca
Medium
Report
Form 144 VERACYTE, INC. Filed by: Chambers Rebecca
11/12
09:35 am
vcyt
Form SC 13G VERACYTE, INC. Filed by: Artisan Partners Limited Partnership
Low
Report
Form SC 13G VERACYTE, INC. Filed by: Artisan Partners Limited Partnership
11/8
10:42 am
vcyt
Form SC 13G/A VERACYTE, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Medium
Report
Form SC 13G/A VERACYTE, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
08:01 am
vcyt
Form 10-Q VERACYTE, INC. For: Sep 30
Medium
Report
Form 10-Q VERACYTE, INC. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 VERACYTE, INC. For: Mar 20 Filed by: Anderson Bonnie H
16.7%
3/25 Form SEC STAFF LETTER VERACYTE, INC. 15.6%
2/29 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.3%
12/4 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 7.9%
4/24 Form DEFA14A VERACYTE, INC. 7.9%
6/27 Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019 7.5%
8/12 Form 4 VERACYTE, INC. For: Aug 09 Filed by: JONES EVAN/ FA 6.7%
10/26 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.5%
4/7 Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations 6.3%
10/19 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.1%
3/25 Form SEC STAFF LETTER VERACYTE, INC. 15.6%
2/29 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.3%
12/4 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 7.9%
4/24 Form DEFA14A VERACYTE, INC. 7.9%
6/27 Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019 7.5%
8/12 Form 4 VERACYTE, INC. For: Aug 09 Filed by: JONES EVAN/ FA 6.7%
10/26 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.5%
4/7 Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations 6.3%
10/19 Veracyte Inc (NASDAQ: VCYT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $29.00 price target on the stock. 6.1%
TOP News Decliners
4/1
Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients
-16.6%
3/11 Form 4 VERACYTE, INC. For: Mar 10 Filed by: Anderson Bonnie H -16.1%
10/22 Veracyte Announces Third Quarter 2019 Financial Results and Business Progress -15.7%
8/13 Form 4 VERACYTE, INC. For: Aug 12 Filed by: Anderson Bonnie H -8.2%
2/21 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.1%
10/24 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -7.3%
9/3 Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer -7.1%
8/1 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.8%
7/30 Form 10-Q VERACYTE, INC. For: Jun 30 -6.7%
4/14 Form 8-K VERACYTE, INC. For: Apr 13 -6.3%
3/11 Form 4 VERACYTE, INC. For: Mar 10 Filed by: Anderson Bonnie H -16.1%
10/22 Veracyte Announces Third Quarter 2019 Financial Results and Business Progress -15.7%
8/13 Form 4 VERACYTE, INC. For: Aug 12 Filed by: Anderson Bonnie H -8.2%
2/21 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.1%
10/24 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -7.3%
9/3 Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer -7.1%
8/1 Veracyte Inc (NASDAQ: VCYT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -6.8%
7/30 Form 10-Q VERACYTE, INC. For: Jun 30 -6.7%
4/14 Form 8-K VERACYTE, INC. For: Apr 13 -6.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: